• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从免疫原性和非免疫原性大鼠脑肿瘤中分离出的肿瘤浸润淋巴细胞的表型和功能活性。

Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.

作者信息

Tzeng J J, Barth R F, Orosz C G, James S M

机构信息

Department of Pathology, Ohio State University, Columbus 43210.

出版信息

Cancer Res. 1991 May 1;51(9):2373-8.

PMID:2015600
Abstract

The purpose of the present study was to define the immunogenicity of two transplantable rat gliomas, designated F98 and D74, and to relate this to the phenotype and functional activity of tumor-infiltrating lymphocytes (TIL). Fischer rats, immunized with irradiated F98 tumor cells and challenged with intracerebral implants of ten F98 cells, had a median survival time of 49 days compared to 36 days for nonimmunized controls. In contrast, no statistically significant increases in survival times were noted in animals similarly immunized and challenged with the D74 tumors. No in vivo protection could be demonstrated in animals immunized and cross-challenged with either F98 or D74 glioma cells. Lymph node lymphocytes and TIL, isolated from animals immunized and challenged with F98 cells, were more cytolytically active than effector cells obtained from D74-immunized animals. Phenotypes of TIL isolated from intracerebral F98 gliomas of immunized rats were 52% OX-8+ and 21% W3/25+ compared to 31% OX-8+ and 19% W3/25+ for D74-immunized animals. Cytolytic activity against glioma targets was mediated by OX-8+ TIL, as determined by cell depletion experiments. Limiting dilution analysis showed that cytolytic T-lymphocyte precursors were present in TIL of F98 gliomas of immunized rats at a frequency of 1/3547 and were specific for F98 targets, while natural killer cell-like activity was low. Our data indicate that the F98 glioma was more immunogenic than the D74 glioma, as evidenced by increased numbers and activity of cytolytic effector cells and their precursors among TIL. This may explain in part the longer survival times observed in immunized animals challenged intracerebrally with the F98 gliomas compared to D74-immunized and -challenged hosts.

摘要

本研究的目的是确定两种可移植大鼠胶质瘤(分别命名为F98和D74)的免疫原性,并将其与肿瘤浸润淋巴细胞(TIL)的表型和功能活性相关联。用经照射的F98肿瘤细胞免疫并经脑内植入10个F98细胞攻击的Fischer大鼠,中位生存时间为49天,而未免疫对照组为36天。相比之下,用D74肿瘤进行类似免疫和攻击的动物,其生存时间没有统计学上的显著增加。在用F98或D74胶质瘤细胞免疫并交叉攻击的动物中,未证明有体内保护作用。从用F98细胞免疫并攻击的动物中分离出的淋巴结淋巴细胞和TIL,比从用D74免疫的动物获得的效应细胞具有更强的细胞溶解活性。从免疫大鼠脑内F98胶质瘤中分离出的TIL的表型为52% OX-8+和21% W3/25+,而用D74免疫的动物为31% OX-8+和19% W3/25+。通过细胞清除实验确定,对胶质瘤靶标的细胞溶解活性由OX-8+ TIL介导。有限稀释分析表明,免疫大鼠F98胶质瘤的TIL中细胞溶解T淋巴细胞前体的频率为1/3547,且对F98靶标具有特异性,而自然杀伤细胞样活性较低。我们的数据表明,F98胶质瘤比D74胶质瘤具有更强的免疫原性,TIL中细胞溶解效应细胞及其前体的数量和活性增加证明了这一点。这可能部分解释了与用D74免疫并攻击的宿主相比,用F98胶质瘤脑内攻击的免疫动物观察到的更长生存时间。

相似文献

1
Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.从免疫原性和非免疫原性大鼠脑肿瘤中分离出的肿瘤浸润淋巴细胞的表型和功能活性。
Cancer Res. 1991 May 1;51(9):2373-8.
2
Quantitation of glioma-reactive cytolytic T lymphocyte precursors by means of limiting dilution analysis.通过有限稀释分析法对胶质瘤反应性细胞溶解性T淋巴细胞前体进行定量分析。
J Immunol Methods. 1992 Feb 5;146(2):177-84. doi: 10.1016/0022-1759(92)90226-j.
3
B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.低免疫原性的F98大鼠胶质瘤细胞所表达的B7.1并不会增强免疫原性。
Gene Ther. 2000 Jun;7(12):993-9. doi: 10.1038/sj.gt.3301209.
4
Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.胶质瘤的细胞因子基因治疗:白细胞介素-4转染的9L胶质肉瘤诱导反应性CD4 + T细胞对保护性免疫至关重要。
Cancer Res. 2000 May 1;60(9):2449-57.
5
Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2.使用淋巴因子激活的杀伤细胞和白细胞介素2对大鼠神经胶质瘤进行过继性免疫治疗。
Cancer Res. 1990 Jul 15;50(14):4338-43.
6
Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.肿瘤浸润淋巴细胞、血液淋巴细胞、脾淋巴细胞及淋巴结淋巴细胞对同基因胶质瘤靶细胞的反应性。
Anticancer Res. 1981;1(3):125-34.
7
Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.用于神经胶质瘤中子俘获治疗的表皮生长因子受体的分子靶向作用
Cancer Res. 2002 Jun 1;62(11):3159-66.
8
Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.通过体外激活的肿瘤引流淋巴结细胞的过继性转移治疗小鼠神经胶质瘤。
Cell Immunol. 1997 Jun 15;178(2):101-7. doi: 10.1006/cimm.1997.1140.
9
Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.对来自人类实体瘤的肿瘤浸润性T淋巴细胞进行克隆和频率分析。
J Immunol. 1987 Jun 1;138(11):4004-11.
10
NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.NKR-P1+细胞选择性地定位于大鼠9L胶质肉瘤中,但细胞溶解功能降低。
Cancer Res. 1996 Aug 1;56(15):3516-25.

引用本文的文献

1
Synergistic effects of herpes oncolytic virus and cyclophosphamide for recurrent malignant glioma: a narrative review.溶瘤性疱疹病毒与环磷酰胺治疗复发性恶性胶质瘤的协同作用:一项叙述性综述
Ann Med Surg (Lond). 2024 Jul 17;86(9):5354-5360. doi: 10.1097/MS9.0000000000002384. eCollection 2024 Sep.
2
Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.用于实验神经肿瘤学研究的大鼠和小鼠脑肿瘤模型。
J Neuropathol Exp Neurol. 2022 Apr 27;81(5):312-329. doi: 10.1093/jnen/nlac021.
3
Radiation Dose-Enhancement Is a Potent Radiotherapeutic Effect of Rare-Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma.
辐射剂量增强是稀土复合纳米闪烁体在胶质母细胞瘤临床前模型中的一种强效放射治疗效应。
Adv Sci (Weinh). 2020 Sep 7;7(20):2001675. doi: 10.1002/advs.202001675. eCollection 2020 Oct.
4
Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide.使用表达荧光素酶的原位大鼠脑肿瘤模型优化靶向照射策略以进行替莫唑胺疗效测试
Cancers (Basel). 2020 Jun 15;12(6):1585. doi: 10.3390/cancers12061585.
5
Glioblastoma Treatments: An Account of Recent Industrial Developments.胶质母细胞瘤的治疗:近期产业发展综述
Front Pharmacol. 2018 Sep 13;9:879. doi: 10.3389/fphar.2018.00879. eCollection 2018.
6
Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models.在啮齿动物胶质母细胞瘤模型中,Toca 511加5-氟胞嘧啶与洛莫司汀联合使用显示出化学毒性和免疫治疗活性,且无附加毒性。
Neuro Oncol. 2016 Oct;18(10):1390-401. doi: 10.1093/neuonc/now089. Epub 2016 May 10.
7
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.在单一部位耗尽肿瘤特异性 Tregs 可消除播散性肿瘤。
J Clin Invest. 2013 Jun;123(6):2447-63. doi: 10.1172/JCI64859.
8
Gene therapy and targeted toxins for glioma.基因治疗与胶质瘤的靶向毒素
Curr Gene Ther. 2011 Jun;11(3):155-80. doi: 10.2174/156652311795684722.
9
Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.脑癌的基因治疗:联合治疗提供了更高的疗效和安全性。
Curr Gene Ther. 2009 Oct;9(5):409-21. doi: 10.2174/156652309789753301.
10
Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.实验神经肿瘤学中的大鼠脑肿瘤模型:C6、9L、T9、RG2、F98、BT4C、RT - 2和CNS - 1胶质瘤。
J Neurooncol. 2009 Sep;94(3):299-312. doi: 10.1007/s11060-009-9875-7. Epub 2009 Apr 21.